Literature DB >> 26173643

Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan Syndrome.

Viviana Cordeddu1,2, Jiani C Yin3, Cecilia Gunnarsson4, Carl Virtanen3, Séverine Drunat5, Francesca Lepri6, Alessandro De Luca7, Cesare Rossi8, Andrea Ciolfi1, Trevor J Pugh3, Alessandro Bruselles1, James R Priest9,10, Len A Pennacchio11,12, Zhibin Lu3, Arnavaz Danesh3, Rene Quevedo3, Alaa Hamid3, Simone Martinelli1, Francesca Pantaleoni1, Maria Gnazzo6, Paola Daniele7, Christina Lissewski13, Gianfranco Bocchinfuso14, Lorenzo Stella14, Sylvie Odent15, Nicole Philip16, Laurence Faivre17, Marketa Vlckova18, Eva Seemanova18, Cristina Digilio6, Martin Zenker13, Giuseppe Zampino19, Alain Verloes5, Bruno Dallapiccola6, Amy E Roberts20, Hélène Cavé5,21, Bruce D Gelb22, Benjamin G Neel3,23, Marco Tartaglia1,6.   

Abstract

The RASopathies constitute a family of autosomal-dominant disorders whose major features include facial dysmorphism, cardiac defects, reduced postnatal growth, variable cognitive deficits, ectodermal and skeletal anomalies, and susceptibility to certain malignancies. Noonan syndrome (NS), the commonest RASopathy, is genetically heterogeneous and caused by functional dysregulation of signal transducers and regulatory proteins with roles in the RAS/extracellular signal-regulated kinase (ERK) signal transduction pathway. Mutations in known disease genes account for approximately 80% of affected individuals. Here, we report that missense mutations altering Son of Sevenless, Drosophila, homolog 2 (SOS2), which encodes a RAS guanine nucleotide exchange factor, occur in a small percentage of subjects with NS. Four missense mutations were identified in five unrelated sporadic cases and families transmitting NS. Disease-causing mutations affected three conserved residues located in the Dbl homology (DH) domain, of which two are directly involved in the intramolecular binding network maintaining SOS2 in its autoinhibited conformation. All mutations were found to promote enhanced signaling from RAS to ERK. Similar to NS-causing SOS1 mutations, the phenotype associated with SOS2 defects is characterized by normal development and growth, as well as marked ectodermal involvement. Unlike SOS1 mutations, however, those in SOS2 are restricted to the DH domain.
© 2015 WILEY PERIODICALS, INC.

Entities:  

Keywords:  Noonan syndrome; RAS signaling; SOS2; genotype-phenotype correlations

Mesh:

Substances:

Year:  2015        PMID: 26173643      PMCID: PMC4604019          DOI: 10.1002/humu.22834

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  32 in total

1.  Ras-guanine nucleotide exchange factor sos2 is dispensable for mouse growth and development.

Authors:  L M Esteban; A Fernández-Medarde; E López; K Yienger; C Guerrero; J M Ward; L Tessarollo; E Santos
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

3.  The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.

Authors:  Konstantin Arnold; Lorenza Bordoli; Jürgen Kopp; Torsten Schwede
Journal:  Bioinformatics       Date:  2005-11-13       Impact factor: 6.937

4.  Structural analysis of autoinhibition in the Ras activator Son of sevenless.

Authors:  Holger Sondermann; Stephen M Soisson; Sean Boykevisch; Shao-Song Yang; Dafna Bar-Sagi; John Kuriyan
Journal:  Cell       Date:  2004-10-29       Impact factor: 41.582

5.  The Ras-specific exchange factors mouse Sos1 (mSos1) and mSos2 are regulated differently: mSos2 contains ubiquitination signals absent in mSos1.

Authors:  K H Nielsen; A G Papageorge; W C Vass; B M Willumsen; D R Lowy
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

6.  Germline gain-of-function mutations in SOS1 cause Noonan syndrome.

Authors:  Amy E Roberts; Toshiyuki Araki; Kenneth D Swanson; Kate T Montgomery; Taryn A Schiripo; Victoria A Joshi; Li Li; Yosuf Yassin; Alex M Tamburino; Benjamin G Neel; Raju S Kucherlapati
Journal:  Nat Genet       Date:  2006-12-03       Impact factor: 38.330

7.  The Sos1 and Sos2 Ras-specific exchange factors: differences in placental expression and signaling properties.

Authors:  X Qian; L Esteban; W C Vass; C Upadhyaya; A G Papageorge; K Yienger; J M Ward; D R Lowy; E Santos
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

8.  Germline gain-of-function mutations in RAF1 cause Noonan syndrome.

Authors:  M Abdur Razzaque; Tsutomu Nishizawa; Yuta Komoike; Hisato Yagi; Michiko Furutani; Ryunosuke Amo; Mitsuhiro Kamisago; Kazuo Momma; Hiroshi Katayama; Masao Nakagawa; Yuko Fujiwara; Masaki Matsushima; Katsumi Mizuno; Mika Tokuyama; Hamao Hirota; Jun Muneuchi; Toru Higashinakagawa; Rumiko Matsuoka
Journal:  Nat Genet       Date:  2007-07-01       Impact factor: 38.330

9.  Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy.

Authors:  Bhaswati Pandit; Anna Sarkozy; Len A Pennacchio; Claudio Carta; Kimihiko Oishi; Simone Martinelli; Edgar A Pogna; Wendy Schackwitz; Anna Ustaszewska; Andrew Landstrom; J Martijn Bos; Steve R Ommen; Giorgia Esposito; Francesca Lepri; Christian Faul; Peter Mundel; Juan P López Siguero; Romano Tenconi; Angelo Selicorni; Cesare Rossi; Laura Mazzanti; Isabella Torrente; Bruno Marino; Maria C Digilio; Giuseppe Zampino; Michael J Ackerman; Bruno Dallapiccola; Marco Tartaglia; Bruce D Gelb
Journal:  Nat Genet       Date:  2007-07-01       Impact factor: 38.330

10.  Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome.

Authors:  Marco Tartaglia; Len A Pennacchio; Chen Zhao; Kamlesh K Yadav; Valentina Fodale; Anna Sarkozy; Bhaswati Pandit; Kimihiko Oishi; Simone Martinelli; Wendy Schackwitz; Anna Ustaszewska; Joel Martin; James Bristow; Claudio Carta; Francesca Lepri; Cinzia Neri; Isabella Vasta; Kate Gibson; Cynthia J Curry; Juan Pedro López Siguero; Maria Cristina Digilio; Giuseppe Zampino; Bruno Dallapiccola; Dafna Bar-Sagi; Bruce D Gelb
Journal:  Nat Genet       Date:  2006-12-13       Impact factor: 38.330

View more
  24 in total

1.  Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.

Authors:  Yline Capri; Elisabetta Flex; Oliver H F Krumbach; Giovanna Carpentieri; Serena Cecchetti; Christina Lißewski; Soheila Rezaei Adariani; Denny Schanze; Julia Brinkmann; Juliette Piard; Francesca Pantaleoni; Francesca R Lepri; Elaine Suk-Ying Goh; Karen Chong; Elliot Stieglitz; Julia Meyer; Alma Kuechler; Nuria C Bramswig; Stephanie Sacharow; Marion Strullu; Yoann Vial; Cédric Vignal; George Kensah; Goran Cuturilo; Neda S Kazemein Jasemi; Radovan Dvorsky; Kristin G Monaghan; Lisa M Vincent; Hélène Cavé; Alain Verloes; Mohammad R Ahmadian; Marco Tartaglia; Martin Zenker
Journal:  Am J Hum Genet       Date:  2019-05-23       Impact factor: 11.025

2.  Differential Role of the RasGEFs Sos1 and Sos2 in Mouse Skin Homeostasis and Carcinogenesis.

Authors:  Pilar Liceras-Boillos; David Jimeno; Rósula García-Navas; L Francisco Lorenzo-Martín; Mauricio Menacho-Marquez; Carmen Segrelles; Carmela Gómez; Nuria Calzada; Rocío Fuentes-Mateos; Jesús M Paramio; Xosé R Bustelo; Fernando C Baltanás; Eugenio Santos
Journal:  Mol Cell Biol       Date:  2018-07-30       Impact factor: 4.272

3.  Mutations in RIT1 cause Noonan syndrome with possible juvenile myelomonocytic leukemia but are not involved in acute lymphoblastic leukemia.

Authors:  Hélène Cavé; Aurélie Caye; Nehla Ghedira; Yline Capri; Nathalie Pouvreau; Natacha Fillot; Aurélien Trimouille; Cédric Vignal; Odile Fenneteau; Yves Alembik; Jean-Luc Alessandri; Patricia Blanchet; Odile Boute; Patrice Bouvagnet; Albert David; Anne Dieux Coeslier; Bérénice Doray; Olivier Dulac; Valérie Drouin-Garraud; Marion Gérard; Delphine Héron; Bertrand Isidor; Didier Lacombe; Stanislas Lyonnet; Laurence Perrin; Marlène Rio; Joëlle Roume; Sylvie Sauvion; Annick Toutain; Catherine Vincent-Delorme; Marjorie Willems; Clarisse Baumann; Alain Verloes
Journal:  Eur J Hum Genet       Date:  2016-01-13       Impact factor: 4.246

Review 4.  A novel heterozygous RIT1 mutation in a patient with Noonan syndrome, leukopenia, and transient myeloproliferation-a review of the literature.

Authors:  Michaela Nemcikova; Sarka Vejvalkova; Filip Fencl; Martina Sukova; Anna Krepelova
Journal:  Eur J Pediatr       Date:  2015-10-31       Impact factor: 3.183

5.  Pathogenetics of the RASopathies.

Authors:  William E Tidyman; Katherine A Rauen
Journal:  Hum Mol Genet       Date:  2016-07-12       Impact factor: 6.150

6.  Biochemical Classification of Disease-associated Mutants of RAS-like Protein Expressed in Many Tissues (RIT1).

Authors:  Zhenhao Fang; Christopher B Marshall; Jiani C Yin; Mohammad T Mazhab-Jafari; Geneviève M C Gasmi-Seabrook; Matthew J Smith; Tadateru Nishikawa; Yang Xu; Benjamin G Neel; Mitsuhiko Ikura
Journal:  J Biol Chem       Date:  2016-05-18       Impact factor: 5.157

7.  Development of Noonan syndrome by deregulation of allosteric SOS autoactivation.

Authors:  Hope Gloria Umutesi; Hanh My Hoang; Hope Elizabeth Johnson; Kwangho Nam; Jongyun Heo
Journal:  J Biol Chem       Date:  2020-08-04       Impact factor: 5.157

8.  Genotype and phenotype spectrum of NRAS germline variants.

Authors:  Franziska Altmüller; Christina Lissewski; Debora Bertola; Elisabetta Flex; Zornitza Stark; Stephanie Spranger; Gareth Baynam; Michelle Buscarilli; Sarah Dyack; Jane Gillis; Helger G Yntema; Francesca Pantaleoni; Rosa LE van Loon; Sara MacKay; Kym Mina; Ina Schanze; Tiong Yang Tan; Maie Walsh; Susan M White; Marena R Niewisch; Sixto García-Miñaúr; Diego Plaza; Mohammad Reza Ahmadian; Hélène Cavé; Marco Tartaglia; Martin Zenker
Journal:  Eur J Hum Genet       Date:  2017-05-03       Impact factor: 4.246

9.  Expansion of the RASopathies.

Authors:  William E Tidyman; Katherine A Rauen
Journal:  Curr Genet Med Rep       Date:  2016-07-01

10.  Identification of quantitative trait loci and candidate genes for an anxiolytic-like response to ethanol in BXD recombinant inbred strains.

Authors:  A H Putman; A R Wolen; J L Harenza; R K Yordanova; B T Webb; E J Chesler; M F Miles
Journal:  Genes Brain Behav       Date:  2016-04       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.